Certain areas of the United States are experiencing a shortage of albuterol quick-relief inhalers, according to the American College of Allergy, Asthma & Immunology (ACAAI). The shortage occurred due to supply chain issues and increased use of albuterol inhalers in hospitals to treat COVID-19 patients in respiratory distress.

 

 

Credit: iStock MementoImage

Read more…